carmustine has been researched along with Lymphocytosis in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Lymphocytosis: Excess of normal lymphocytes in the blood or in any effusion.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Laport, GG | 1 |
Levine, BL | 1 |
Stadtmauer, EA | 1 |
Schuster, SJ | 1 |
Luger, SM | 1 |
Grupp, S | 1 |
Bunin, N | 1 |
Strobl, FJ | 1 |
Cotte, J | 1 |
Zheng, Z | 1 |
Gregson, B | 1 |
Rivers, P | 1 |
Vonderheide, RH | 1 |
Liebowitz, DN | 1 |
Porter, DL | 1 |
June, CH | 1 |
Icli, F | 1 |
Ezdinli, EZ | 1 |
Costello, W | 1 |
Berard, CW | 1 |
Bennett, JM | 1 |
Carbone, PP | 1 |
1 trial available for carmustine and Lymphocytosis
Article | Year |
---|---|
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation.
Topics: Adolescent; Adoptive Transfer; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Pro | 2003 |
1 other study available for carmustine and Lymphocytosis
Article | Year |
---|---|
Diffuse well-differentiated lymphocytic lymphoma (DLWD): response and survival.
Topics: Aged; Antineoplastic Agents; Carmustine; Cell Differentiation; Chlorambucil; Cyclophosphamide; Drug | 1978 |